Isoproterenol-evoked renin release from the in situ perfused kidney. Dose-response characteristics in spontaneously hypertensive and normotensive Wistar Rats.

10. Sealcy JE, Gerten-Bancs J, Laragh JH: The rcnin system, variations in man measured by radkxmmunoassay or bioassay. Kidney Int 1: 240-253, 1972 11. Laragh JH: Vasoconstriction-volumc analysis for understanding and treating hypertension: The use of renin and aldosterone profiles. Am J Med 5S: 261-274, 1973 12. BOhler FR, Laragh JH, Baer L, Vaughan ED Jr, Brunncr HR: Propropanolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 287: 1209-1213, 1972 13. Tobian L, Janecek J, Folter J, Ferriera D: Effect of chlorthiaride on renal jiuctaglomerular cells and tissue electrolytes. Am J Physiol 202: 905-908, 1962 14. Weinberger MH, Ramsdell JW, Rosner DR, Gcddes JJL: Effect of chlorthiazide and sodium on vascular responsiveness to angiotensin II Am J Physiol 223: 1049-1052, 1972 15. Gavras H, Brunncr HR, Vaughan ED Jr, Laragh JH. Angiotensinsodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 180: 1369-1372, 1973 16. Kimbrough HM Jr, Vaughan ED Jr, Carey RM, Ayers CR: Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.CircRcs40: 174-178, 1977 17. Ayera CR, Vaughan ED Jr, Yancey MR. Bing KT, Johnson CC, Morton C: Effect of sar'-ala'-angiotensin II and convening enzyme inhibition on renin release in dogs with acute renovascular hypertension. Circ Res 34/35 (suppl 1): 27-33, 1974 18. Case DB, Wallace JM, Keim HJ, Sealey JE, Laragh JH: Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II for evaluating the renin and sodium factors in hypertensive patients Am J Med 60: 825-836, 1976 19. Carey RM, Vaughan ED Jr, Ackerly JA, Peach MJ, Ayers CR: Mechanism of the pressor effect of sar'-ala"-angiotcnsin II in man. Circulation 54: 11-87, 1976 20. Streeten DHP, Anderson GH, Freiberg JM. Dalakos TG: Use of angiotensin II antagonist (saralasin) in hypertensive subjects. Circ Res 40: 243-250, 1977 21. Ajiderson GH, Streeten DHP, Dalakos TG: Pressor response to l-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects. Circ Res 40: 243-250, 1977 22. Baer L, Parra-Carrillo JZ, Radichevich I, Williams GS: Detection of renovascular hypertension with angiotensin II blockade. Ann Int Med 86: 257-260, 1977 23. Noth RH, Mulrow PJ: Serum dopamine-/3-hydroxylase as an index of sympathetic nervous system activity in man. Circ Res 38: 2-5, 1976 24. Esler M, Randall P, Bennett J, Zweifler A, Julius S, Rydelek P: Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet 2: 115-118, 1976